The ratio of effective arterial elastance (Ea) to left ventricular elastance (Ees) is an indicator of the coupling between ventricular properties and arterial load properties. Another criterion for the coupling between an energy source and its load is the principle of economical fuel consumption, or mechanical efficiency, which is defined as the ratio of stroke work (SW) to myocardial oxygen consumption per beat (MVO 2 ). It has been revealed that SW of ventricular contraction is maximized when Ea/Ees:1, while mechanical efficiency is maximized when Ea/Ees:0.5. The purpose of the present study was to investigate the ventriculo-arterial coupling during hypertension, and the effects of nicardipine on this relationship in surgical patients using Ea/Ees and SW/MVO 2 as indicators. Anaesthesia was maintained with isoflurane, nitrous oxide, and fentanyl. Radial artery pressure was displayed on a polygraph, and left ventricular end-systolic and end-diastolic volumes were determined by use of transoesophageal echocardiography. Ees was calculated as MAP/(ESVI-4), where MAP is mean arterial pressure and ESVI is end-systolic volume index. Ea was calculated as the ratio of MAP to stroke volume index (SVI). Stroke work index (SWI) was calculated as the product of MAP and SVI. MVO 2 was assessed by estimating the ventricular pressure-volume area index (PVAI), which is expressed as the sum of SWI and the end-systolic potential energy index. Before (baseline), and 3, 10, 20, and 30 min after i.v. nicardipine (30 g kg 91 ), Ea/Ees and SWI/PVAI were determined in 14 surgical patients with intraoperative hypertension. Before nicardipine (during hypertension), Ea was almost equal to Ees, whereas Ea/Ees was significantly reduced to about 0.5-0.6 at 3, 10, and 20 min after nicardipine. SWI/PVAl was maximized and significantly greater than the baseline value at 3 min after nicardipine. These results suggest that, during hypertension, ventricular and arterial properties were so matched as to maximize SW at the expense of the work efficiency, whereas mechanical efficiency of ventricular contraction was maximized after nicardipine. (Br.
The ratio of effective arterial elastance (Ea) to left ventricular elastance (Ees) is an indicator of the coupling between ventricular properties and arterial load properties. Another criterion for the coupling between an energy source and its load is the principle of economical fuel consumption, or mechanical efficiency, which is defined as the ratio of stroke work (SW) to myocardial oxygen consumption per beat (MVO 2 ). It has been revealed that SW of ventricular contraction is maximized when Ea/Ees:1, while mechanical efficiency is maximized when Ea/Ees:0.5. The purpose of the present study was to investigate the ventriculo-arterial coupling during hypertension, and the effects of nicardipine on this relationship in surgical patients using Ea/Ees and SW/MVO 2 as indicators. Anaesthesia was maintained with isoflurane, nitrous oxide, and fentanyl. Radial artery pressure was displayed on a polygraph, and left ventricular end-systolic and end-diastolic volumes were determined by use of transoesophageal echocardiography. Ees was calculated as MAP/(ESVI-4), where MAP is mean arterial pressure and ESVI is end-systolic volume index. Ea was calculated as the ratio of MAP to stroke volume index (SVI). Stroke work index (SWI) was calculated as the product of MAP and SVI. MVO 2 was assessed by estimating the ventricular pressure-volume area index (PVAI), which is expressed as the sum of SWI and the end-systolic potential energy index. Before (baseline), and 3, 10, 20, and 30 min after i.v. nicardipine (30 g kg 91 ), Ea/Ees and SWI/PVAI were determined in 14 surgical patients with intraoperative hypertension. Before nicardipine (during hypertension), Ea was almost equal to Ees, whereas Ea/Ees was significantly reduced to about 0.5-0.6 at 3, 10, and 20 min after nicardipine. SWI/PVAl was maximized and significantly greater than the baseline value at 3 min after nicardipine. These results suggest that, during hypertension, ventricular and arterial properties were so matched as to maximize SW at the expense of the work efficiency, whereas mechanical efficiency of ventricular contraction was maximized after nicardipine. (Br. J. Anaesth. 1998; 81: 180-185) Keywords: measurement techniques, elastance; heart, stroke work; heart, ventrico-arterial coupling; oxygen, consumption; monitoring, transoesophageal echocardiography; calcium channel block There has been long-standing interest in understanding the interaction between the heart and vasculature. A number of studies [1] [2] [3] [4] [5] [6] [7] [8] have been performed to answer the question: what is the optimal coupling between the ventricle and arterial load under physiological and pathological circumstances? Sunagawa and colleagues 1 2 theoretically predicted and experimentally validated in isolated canine heart that maximization of left ventricular stroke work (SW) occurs under physiological conditions. Other groups, 3-5 8 showed that the normal ventricle yields maximum SW against normal arterial afterload in anaesthetized open-chested dogs and cats. In contrast, using a simple analytical model for the interaction between the heart and vasculature, particularly with regards to the ratio of SW to ventricular oxygen consumption (MVO 2 ), defined as mechanical efficiency, Burkhoff and Sagawa 6 concluded that SW of ventricular contraction is maximized when the ratio of effective arterial elastance (Ea) to left ventricular elastance (Ees) is 1, while mechanical efficiency is maximized when Ea/Ees:0.5. They also suggested that, under physiological conditions, ventricular and arterial properties might be adjusted more toward optimization of efficiency than SW. Asanoi, Sasayama and Kameyama 7 tried to extend these observations to humans and showed that in patients with normal heart function Ea/Ees was approximately 0.5, but in patients with moderate myocardial depression Ea was almost equal to Ees. Burkhoff and Sagawa 6 speculated that these discrepancies might be explained by the unphysiological conditions of isolated heart and instrumental, open-chest animal preparations. Nevertheless, it is not known whether regulation of the heart and arterial system during anaesthesia and surgery in humans is orientated towards maximizing work or efficiency. The ultimate goal of this investigation was to study the ventriculo-arterial coupling in patients under general anaesthesia with arterial hypertension and after treatment of the hypertension with nicardipine by using Ea/Ees and SW/MVO 2 as indicators.
Patients and methods
Fifty-four ASA class II patients scheduled for noncardiac surgery agreed to participate in this study. They developed hypertension (systolic arterial pressure Ն150 mm Hg or diastolic arterial pressure Ն90 mm Hg) for at least 5 min after surgical stimulation. These patients had hypertension as part of their preoperative pathology; had no evidence of heart failure or other forms of heart disease; and were in normal sinus rhythm without conduction abnormalities. They were not taking cardiac active medications, but most of them were taking antihypertensive, mainly vasodilating drugs. Our study design was approved by the Hospital Committee on Human Study, and written informed consent was obtained from all patients. Patients were premedicated with i.m. atropine 0.5 mg and hydroxizine 50 mg 30 min before arrival in the operating theatre. Anaesthesia was induced with thiopental 3 mg kg
91
, and maintained with 50-65% nitrous oxide, 0.5-2% isoflurane, and increments of fentanyl. Vecuronium was given to facilitate tracheal intubation. Ventilation was controlled to maintain 
DOSE-DEPENDENT EFFECTS ON SYSTOLIC ARTERIAL

PRESSURE
To define the effective clinical dose of the drug that would produce a satisfactory initial lowering of arterial pressure, the dose-response relation for i.v. nicardipine was studied in 40 patients (male/female:l6/24, age 48 years old) who developed hypertension for at least 5 min after surgical stimulation. An i.v. bolus of nicardipine in the dose range of 0.5 to 50 g kg 91 was administered over 15 sec, and systolic arterial pressure was measured before (baseline) and every minute after nicardipine by use of an automatic blood pressure device (Nihon Colin BP-203i, Komaki, Japan) until the peak effects of nicardipine were obtained. Forty data points obtained in 40 patients were plotted as nicardipine doses compared with the ratio of systolic arterial pressure at the peak effects of nicardipine to those at baseline (expressed as % of baseline). These data were converted to probits and the dose-response equation was calculated by least-square curve fitting.
CARDIAC HAEMODYNAMIC EFFECTS
Subsequently, the cardiac haemodynamic effects of i.v. nicardipine (30 g kg 91 ) were evaluated in 14 patients (male/female:7/7, age 60 [45-68] years old) who developed hypertension for at least 5 min after surgical stimulation. All 14 patients were scheduled for major surgical interventions that required invasive cardiovascular monitoring. After induction of anaesthesia, a 22-gauge cannula was inserted into a radial artery for measurement of the systemic arterial pressure and blood sampling, and a triple-lumen thermodilution pulmonary artery catheter was placed in a pulmonary artery through the right internal jugular vein. The transducer of the transoesophageal echocardiography device (TEE, Aloka UST-5233 S-5,Tokyo, Japan) was inserted orally into the oesophagus and advanced firmly into the stomach with upward tilting of the tip. A cross-section of the left ventricle was visualized by transoesophageal two-dimensional echocardiography and an M-mode echogram obtained at the maximum antero-posterior diameter. This method was identical to that described by Matsuzaki, Toma and Kusukawa. 9 The ECG was simultaneously recorded with the M-mode. Before (baseline), and 3, 10, 20, and 30 min after i.v. administration of nicardipine, cardiac haemodynamic variables were measured. Measurements included heart rate (HR), systolic-, diastolic-, and mean-arterial pressure (AP), cardiac output (CO), systolic-, diastolic-, and meanpulmonary arterial pressure (PAP), mean pulmonary capillary wedge pressure (PCWP), central venous pressure (CVP), and left ventricular end-diastolic (EDD) and end-systolic diameters (ESD).The EDD was obtained at the onset of the QRS complex of the ECG, and the ESD at the peak of the anterior wall motion. 10 Left ventricular end-diastolic volume (EDV) and end-systolic volume (ESV) were calculated from a previously validated Teichholz method. 11 As with the study of Asanoi, Sasayama and Kameyama, 7 stroke volume (SV), CO, EDV, and ESV were normalized for body surface area (SVI, CI, EDVI, and ESVI). Systemic vascular resistance index (SVRI), pulmonary vascular resistance index (PVRI), fractional shortening (FS), and ejection fraction (EF) were derived using standard formulae. Arterial blood samples were obtained to measure isoflurane and nicardipine plasma concentrations. Concentrations of isoflurane in plasma were determined by gas chromatography (Shimadzu GC-4, Tokyo, Japan), and those of nicardipine were determined by use of high-performance liquid chromatography (Shimadzu LC-1, Tokyo, Japan). The lower limits of detection of the assay for isoflurane and nicardipine plasma concentrations were approximately 0.1 mg dl 91 and 1 ng ml
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, respectively. Overall the coefficient of variation was between 5%-10% for both isoflurane and nicardipine measurements.
EFFECTS ON VENTRICULO-ARTERIAL COUPLING
To investigate coupling between the heart and arterial system in surgical patients, we estimated the slope of the left ventricular end-systolic pressure-volume relation (Ees), the slope of the arterial end-systolic pressure-stroke volume relation (Ea), stroke work index (SWI), and myocardial oxygen consumption (MVO 2 ) using the cardiac haemodynamic data obtained in the second trial (tables 1 and 2). In the present study, we did not generate multiple pressure-volume loops under multiple preload or afterload conditions but, based on the work of Asanoi, Sasayama and Kameyama 7 evaluating the ventriculo-arterial coupling in normal subjects and cardiac patients, we estimated that V0, that is the left ventricular volume at theoretical pressure zero, is 4 ml m 92 in normal subjects. Thus, Ees was calculated as MAP/(ESVI-4) and Ea as MAP/SVI, 7 where MAP is mean arterial pressure, ESVI is end-systolic volume index, and SVI is stroke volume index. We also analysed the ventriculo-arterial matching by using another criterion for optimal coupling between an energy source and its load-that is, the principle of economical fuel consumption or mechanical efficiency. 6 In the case of the heart, the mechanical efficiency is defined as the ratio of SW to myocardial oxygen consumption per beat (MVO 2 ). Based on the work of Asanoi, Sasayama and Kameyama, 7 we approximated SWI as the product of MAP and SVI (SWI:MAP SVI). MVO 2 was assessed by estimating the ventricular pressure-volume area index (PVAI), which has been shown to be linearly related to oxygen consumption when basal inotropic state does not vary. 12 13 The PVAI is defined as the area on the ventricular pressure-volume (P-V) diagram circumscribed by the end-systolic and end-diastolic P-V relations and the systolic portion of the P-V trajectory. PVAI can therefore be expressed as the sum of SWI and the end-systolic potential energy index (PEI), which is represented by the area of the triangle defined by the end-systolic P-V relation, the end-diastolic P-V relation, and the isovolumic relaxation portion of the ventricular P-V trajectory (see fig. 1 of reference 6 ).
Data were presented as mean (SD). Statistical analyses were accomplished by one-way ANOVA with Scheffe F test. P:0.05 was considered to be statistically significant. , systolic arterial pressure declined in a dose-dependent manner ( fig. 1 ) and reached a nadir 2-3 min after injection. Complications such as severe hypotension or disturbances of atrioventricular conductance did not occur. The doseresponse equation obtained in this trial-that is, probit:90.97 log (dose);7.01, indicates that nicardipine 6 g kg 91 and 24 g kg 91 produce 10% and 25% reduction in systolic arterial pressure.
Results
DOSE-DEPENDENT EFFECTS
CARDIAC HAEMODYNAMIC EFFECTS
The time course of the cardiac haemodynamic effects of nicardipine 30 g kg 91 assessed by radial artery and pulmonary artery catheters are summarized in table 1, and those assessed by TEE in table 2. (6) 15 (6) 12 (5) 11 (6) 13 (6) CVP (mm Hg) 8 (3) 9 (4) 9 (4) 7 (4) 8 (4) Three minutes after i.v. administration, nicardipine 30 g kg 91 produced significant decreases in AP and SVRI, and significant increases in SVI, CI, FS, and EF. Nicardipine also produced a significant reduction in ESVI at 10 min after i.v. injection. After the peak effects, SVI, CI, ESVI, FS, and EF returned to the baseline values within 20 min, whereas AP and SVRI were significantly less than the baseline values even at 30 min after nicardipine administration. Other haemodynamic variables did not change significantly.
EFFECTS ON VENTRICULO-ARTERIAL COUPLING
Before nicardipine, Ea was almost equal to Ees ( fig.  2, upper panel) . Three, 10, and 20 min after i.v. administration, nicardipine 30 g kg 91 produced small increases in Ees as compared with baseline values, but the differences did not reach statistical significance ( fig. 2, upper panel) . In contrast, there was a large and statistically significant decrease in the slope of Ea at 3, 10, 20, and 30 min after nicardipine ( fig. 2, upper panel) . As a result, Ea/Ees was significantly reduced from nearly 0.9 (baseline, a value obtained during hypertension) to 0.5-0.6 at 3, 10, and 20 min after nicardipine ( fig. 2, lower panel) . Both SWI and PVAI tended to decrease after nicardipine as compared with baseline values, but the differences did not reach statistical significance ( fig. 3, upper panel) . SWI/PVAI was significantly increased at 3 min after i.v. administration of nicardipine ( fig. 3, lower panel) . 
Discussion
The most important findings of the present study are that, during hypertension, ventricular and arterial properties were matched so as to maximize stroke work at the expense of the work efficiency, whereas mechanical efficiency of ventricular contraction was maximized after nicardipine. We investigated the ventriculo-arterial coupling in patients under general anaesthesia with arterial hypertension and after sufficient treatment of hypertension with nicardipine by using Ea/Ees and SWI/PVAI as indicators. As the arterial system and the left ventricle can be treated as elastic chambers that have volume elastance, Ea and Ees (at end-systole) respectively, the distribution of the volume between the two chambers can be determined by the ratio of their volume elastance values. 14 Thus, the ratio of Ea to Ees is an indicator of the coupling between ventricular properties and arterial load properties. Another criterion for the coupling between an energy source and its load is the principle of economical fuel consumption, or mechanical efficiency, which is defined as the ratio of stroke work (SW) to myocardial oxygen consumption per beat (MVO 2 ). MVO 2 was assessed by estimating the ventricular pressure-volume area index (PVAI). Suga and his colleagues 12 13 have demonstrated that left ventricular PVA is linearly related to MVO 2 per beat at a given heart rate with a stable inotropic background. As shown in figs. 2 and 3, Ea was almost equal to Ees before nicardipine (during hypertension), as predicted by Burkhoff and Sagawa 6 to achieve maximal SW. Ea/Ees was significantly reduced to 0.5-0.6 at 3, 10, and 20 min, and SWI/PVAI was maximized at 3 min after nicardipine to achieve maximal mechanical efficiency.
Based on the dose-response equation obtained in the present study ( fig. 1) , we predicted that the effective clinical dose of nicardipine for treatment of hypertension during anaesthesia and surgery would be 25-30 g kg
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. I.v. administration of nicardipine 30 g kg 91 produced significant reductions in AP, SVRI, and ESVI, and significant increases in SVI, CI, FS, and EF (tables 1 and 2). Other haemodynamic variables including PCWP, CVP, and EDVI did not change significantly. Isoflurane plasma concentrations did not change significantly throughout the study period excluding the possibility that changes in isoflurane concentration produced the changes observed. The direction and magnitude of changes in the haemodynamic variables produced by nicardipine were similar to those reported previously in patients with, hypertension, 15 heart failure, 16 and ischaemic heart disease, 17 or in surgical patients with intraoperative 18 or postoperative hypertension. 19 Among the haemodynamic variables, FS and EF are well accepted as clinically useful quantitative measurements of ventricular performance. However, their usefulness as measures of ventricular contractility are limited because both FS and EF are clearly afterload-dependent, and arguably preload-dependent. 20 In the search for a measure of ventricular function that is independent of loading conditions, Suga, Sagawa and Shoukas 21 showed in canine left ventricle that Ees is sensitive to changes in contractility. Sunagawa and colleagues 14 extended the ventricular pressure-volume analysis to include its interaction with the arterial bed and revealed that, given a constant heart rate, the arterial properties can be represented as an effective arterial elastance Ea. Although extremely useful for the evaluation of direct myocardial actions and peripheral actions of new drugs, the practical clinical application of Ees and Ea has been limited mainly for three reasons. First, easily applicable in vivo technology to measure ventricular volumes is not available in many clinical settings. 22 In the present study, we used TEE for measurement of left ventricular dimensions, and calculated left ventricular volumes by the formula of Teichholz and colleagues. 11 These and other groups 7 11 23 have reported the validity of echocardiography in evaluating left ventricular volumes. Second, determination of true end-systolic pressure (Pes) requires left ventricular or aortic pressure measurement. It has been demonstrated in humans 24 and predicted theoretically 1 that Pes in the arterial system can be approximated by mean arterial pressure (MAP). Thus, we assumed in the present study that left ventricular Pes is very close to MAP. The use of arterial pressure data obviates the potential added risk associated with left ventricular or aortic catheter placement. 25 Third, manipulation of arterial pressure in order to obtain different pressure-volume points may cause reflex inotropic changes, evidenced by increased or decreased heart rate, because of sympathetic activation or withdrawal. 20 A recently developed method for the estimation of Ees and V0 from analysis of single-beats indicated good correlation with measured values obtained by standard multiple-beat analysis. 26 In the present study, we did not generate multiple pressure-volume loops under multiple preload or afterload conditions, but we assumed that V0 is 4 ml m 92 7 and calculated Ees as MAP/(ESVI-4). By so doing, any single pressure-volume loop could allow us to estimate Ees without manipulation of arterial pressure.
Three and 10 min after i.v. administration, nicardipine 30 g kg 91 produced a small increase in Ees ( fig. 2,  upper panel) . This slight increase in Ees might be partly baroreflex-mediated. 17 If so, these data indicate that direct cardiac actions of nicardipine are very minimal and transient. In contrast, there was a large and statistically significant decrease in the slope of Ea ( fig.  2, upper panel) . As Ea reflects afterload in the face of constant HR, left ventricular preload, and left ventricular contractility, 14 the observed significant reduction in Ea without significant changes in HR, PCWP, EDVI, and Ees, indicates a strong vascular selectivity of nicardipine (tables 1 and 2, fig. 2 ). Figure 3 Effects of nicardipine on stroke work index (SWI) and ventricular pressure-volume area index (PVAI). Both SWI and PVAI tended to be reduced after nicardipine as compared with baseline value (B), but the differences did not reach statistical significance (upper panel). SWI/PVAI was maximized and significantly greater than the baseline value at 3 min after nicardipine (lower panel).
